In vitro activity of BMY-28142 in comparison with those of other beta-lactam antimicrobial agents.

The in vitro susceptibility of 406 clinical isolates to BMY-28142, a new semisynthetic cephem, was evaluated and compared with cefpimizole, HR 810, ceftazidime, cefotaxime, moxalactam, and cefoperazone in a broth microdilution assay. On a weight basis, the activity of BMY-28142 against Escherichia c...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	Antimicrob Agents Chemother
Principais autores:	Tsuji, A, Maniatis, A, Bertram, M A, Young, L S
Format:	Artigo
Sprog:	Inglês
Udgivet:	American Society for Microbiology (ASM) 1985
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180087/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3839120/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.27.4.515
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!